Spritam--a new formulation of levetiracetam for epilepsy.
D000284:Administration, Oral; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D058256:Brain Waves / Q000187:drug effects*; D004334:Drug Administration Schedule; D004339:Drug Compounding; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D000077287:Levetiracetam; D010889:Piracetam / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013607:Tablets; D016896:Treatment Outcome
D000927:Anticonvulsants; D013607:Tablets; D000077287:Levetiracetam; D010889:Piracetam